106
panel
Future Generations of Giving: Long-Term Philanthropy Strategy in Short-Term Uncertainty (Invite only)
For families, corporations, and foundations engaged in philanthropy, the shifting global landsca
pe prompts inquiry into future strategies around decision-making, governance, and impact of their giving in the long-term.
+ Read More
panel
Global Asset Management in Transition: Innovation, Risk, and the Road Ahead
The global asset management sector is undergoing a fundamental shift in strategy as firms adapt
to persistent market volatility, interest rate uncertainty, and heightened political and regulatory uncertainty.
+ Read More
panel
How South-South Investments are Accelerating the Rise of the Rest
As the world gradually shifts from a unipolar toward a multipolar geopolitical order, the Global
South is assuming a broader functional role across economic, diplomatic, and strategic arenas.
+ Read More
panel
The Asia Pacific Investment Outlook
panel
The New World Order of Biomedical Innovation
For decades, substantial public investment—particularly in nations such as the United States and
Singapore—has driven biomedical research.
+ Read More
panel
Asia Summit Check-in
panel
Closing Plenary
video
From Success to Significance: A Legacy of Purpose for Longer Lives
Longer life means more time for family, friends and leisure, but the opportunities to make a diffe
rence in the world are bigger than that.
+ Read More
video
Interview with Gayle Smith: Building Global Leadership for an Inclusive COVID-19 Recovery
COVID-19 Africa Watch talks to Gayle Smith, President and CEO of the ONE Campaign, about the globa
l response to COVID-19, inclusive access to an eventual vaccine, and the role of civil society in responding to the pandemic.
+ Read More
video
Tunde Fafunwa: The Case for Digital Identity in Africa during and post-COVID-19
COVID-19 Africa Watch talks to Tunde Fafunwa, Lead Advisor for the UNECA Digital Centre for Excell
ence, about the importance of digital identity for economic recovery.
+ Read More
article
Comment Letter: Food and Drug Administration (FDA) – Medical Device User Fee Act (MDUFA)
Dear Commissioner Hahn: